News Breaks |
|
|
| October 16, 2012 |
| 07:50 EDT |  | JNJ | Johnson & Johnson says Synthes contributed 5.8% to worldwide sales growth
|
|
|
News For JNJ From The Last 14 Days Check below for free stories on JNJ the last two weeks. |
|
|
| May 24, 2013 |
| 07:54 EDT |  | JNJ | Johnson & Johnson drug business should maintain momentum, says Wells Fargo
After attending J&J's bi-annual pharmaceutical business review, Wells Fargo believes that the revenue generated by four of the company's new drugs could double from 2012 to 2015. The firm thinks the company's pharmaceutical unit has one of the best growth outlooks in the sector, and it keeps an Outperform rating on the stock. |
|
| 06:28 EDT | | JNJ | Johnson & Johnson price target raised to $94 from $88 at Leerink
 Subscribe for More Information |
|
| May 23, 2013 |
| 10:08 EDT |  | JNJ | On The Fly: Analyst Initiation Summary
Subscribe for More Information |
|
| 07:31 EDT | | JNJ | Janssen expects to have more than 25 brand line extensions by 2017
Subscribe for More Information |
|
| 06:29 EDT | | JNJ | Johnson & Johnson coverage assumed with an Underperform at Credit Suisse
Subscribe for More Information |
|
| May 22, 2013 |
| 16:00 EDT |  | JNJ | Options Update; May 22, 2013
Subscribe for More Information |
|
| May 21, 2013 |
| 07:24 EDT |  | JNJ | Global Health Care to host a conference
Subscribe for More Information |
|
| May 17, 2013 |
| 06:19 EDT |  | JNJ | J&J to end sales of of metal-on-metal hip replacements, Bloomberg reports
Subscribe for More Information |
|
| May 15, 2013 |
| 16:51 EDT | | JNJ | FDA approves Simponi to treat ulcerative colitis
Subscribe for More Information |
|
|
|
|
|
